Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market

Journal article

Open access

Peer reviewed

Emma Boswell Dean, Amelia M. Bond and Emma Claire Boswell Dean

JAMA health forum, Vol.2(9), p.e212634

2021-09-03

Files and links (1)

url

https://doi.org/10.1001/jamahealthforum.2021.2634View

Published (Version of record) Open

5 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market
Creators: Emma Boswell Dean - University of Miami
Amelia M. Bond - Cornell University
Emma Claire Boswell Dean - SBA - Health Sector Management and Policy
Publication Details: JAMA health forum, Vol.2(9), p.e212634
Academic Unit: Miami Herbert Business School; MHBS - Health Sector Management and Policy
Language: English
Resource Type: Journal article
Record Identifier: 991031714355402976